Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$70.37 USD

70.37
1,742,354

+0.14 (0.20%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $70.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Henry Schein (HSIC) Might Surprise This Earnings Season

by Zacks Equity Research

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

by Zacks Equity Research

Better-than-expected performance at Pharmaceutical and Medical segments are likely to aid Cardinal Health's (CAH) in Q4 earnings.

Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?

by Zacks Equity Research

Henry Schein (HSIC) is working diligently to grow in the field of digital dentistry, globally.

Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings?

by Zacks Equity Research

GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?

by Zacks Equity Research

Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.

What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?

by Zacks Equity Research

Better-than-expected performance at Technology & Equipment and growth in emerging markets are likely to aid DENTSPLY SIRONA (XRAY) in Q2 earnings.

Can IDEXX's (IDXX) International Growth Drive Q2 Earnings?

by Zacks Equity Research

In the United States, IDEXX (IDXX) witnesses a strong uptrend in CAG Diagnostic recurring revenues.

AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Better-than-expected performance at Pharmaceutical Distribution and higher revenues are likely to aid AmerisourceBergen (ABC) in Q3 earnings.

Why Henry Schein (HSIC) Could Beat Earnings Estimates Again

by Zacks Equity Research

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Henry Schein Closes Acquisition of Elite Computer Italia

by Zacks Equity Research

The Elite Computer acquisition marks Henry Schein's (HSIC) foray into the Italian dental practice management software market.

HSIC vs. WST: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

HSIC vs. WST: Which Stock Is the Better Value Option?

What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

by Zacks Equity Research

Patterson Companies (PDCO) expects to gain from the Animal Health unit in fourth-quarter fiscal 2019.

HSIC vs. MMSI: Which Stock Is the Better Value Option?

by Zacks Equity Research

HSIC vs. MMSI: Which Stock Is the Better Value Option?

Why Is Henry Schein (HSIC) Down 1.6% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sreyoshi Mukherjee headshot

Medical Dental Supplies Industry Outlook: Growth Scope Wide

by Sreyoshi Mukherjee

Near-term prospects look bright for the Zacks Medical Dental Supplies industry, thanks to laser dentistry and robotics.

Urmimala Biswas headshot

Henry Schein's (HSIC) Q1 Earnings, Revenues Beat Estimates

by Urmimala Biswas

Henry Schein's (HSIC) strong share gains in the North American market raise optimism.

Henry Schein (HSIC) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 5.26% and 0.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Can Dental Growth Drive Henry Schein's (HSIC) Q1 Earnings?

by Zacks Equity Research

Henry Schein (HSIC) is consistently riding on segmental strength at Dental, Medical and Technology plus Value-Added Services.

Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Henry Schein (HSIC) Up 2.1% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for March 21st

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Henry Schein's New Buyout to Boost Dental Technology Business

by Zacks Equity Research

Henry Schein (HSIC) expects the acquisition to be neutral to its 2019 earnings per diluted share and accretive thereafter.

Henry Schien Buys North American Rescue, Expands Medical Arm

by Zacks Equity Research

Henry Schien (HSIC) believes that acquisition of NAR's business will offer multiple growth opportunities and promising business synergies.

Moving Average Crossover Alert: Henry Schein

by Zacks Equity Research

Henry Schein, Inc. (HSIC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.